Ikarian Healthcare Master Fund, L.P., 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), bought 631,698 shares at $2.87 ($2.1M) on 2020-09-04, disclosed to the SEC on 2020-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.87 | 151,611 | $435K | 20.9% |
| 2 | $2.87 | 151,611 | $435K | 20.9% |
| 3 | $2.90 | 13,244 | $38K | 1.8% |
| 4 | $3.49 | 79,415 | $277K | 13.3% |
| 5 | $3.49 | 79,415 | $277K | 13.3% |
| 6 | $3.93 | 78,201 |
| $307K |
| 14.8% |
| 7 | $3.93 | 78,201 | $307K | 14.8% |
| Total | $3.29 avg | 631,698 | $2.1M | 100% |